Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Biotech Gwth (BIOG) Share Price

Price 1,324.00p on 16-10-2026 at 16:55:14
Change -58.00p -4.2%
Buy 1,328.00p
Sell 1,324.00p
Last Trade: Sell 1,992.00 at 1,324.00p
Day's Volume: 19,731
Last Close: 1,324.00p
Open: 1,374.00p
ISIN: GB0000385517
Day's Range 1,324.00p - 1,374.00p
52wk Range: 1,055.00p - 1,786.00p
Market Capitalisation: £248.44m
VWAP: 1,352.30294p
Shares in Issue: 18.76m

Biotech Gwth (BIOG) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 1,992 1,324.00p Uncrossing Trade
16:35:06 - 16-Oct-26
Sell* 600 1,324.3431p Ordinary
16:26:11 - 16-Oct-26
Buy* 152 1,328.00p Automatic Execution
16:24:36 - 16-Oct-26
Unknown* 0 1,332.00p SI Trade
16:24:22 - 16-Oct-26
Sell* 48 1,326.00p Automatic Execution
16:24:22 - 16-Oct-26
Sell* 152 1,326.00p Automatic Execution
16:23:29 - 16-Oct-26
Buy* 200 1,328.00p Automatic Execution
16:21:13 - 16-Oct-26
Buy* 400 1,326.00p Automatic Execution
16:21:09 - 16-Oct-26
Unknown* 0 1,330.00p SI Trade
16:21:01 - 16-Oct-26
Buy* 100 1,330.00p Automatic Execution
16:19:13 - 16-Oct-26
See more Biotech Gwth trades

Biotech Gwth (BIOG) Share Price History

Time period:
to
Date Open High Low Close Volume
16th Oct 2026 (Fri) 1,374.00 1,374.00 1,324.00 1,324.00 19,731
15th Oct 2026 (Thu) 1,332.00 1,382.00 1,332.00 1,382.00 56,632
14th Oct 2026 (Wed) 1,354.00 1,358.00 1,334.00 1,358.00 62,941
13th Oct 2026 (Tue) 1,394.00 1,402.00 1,350.00 1,356.00 76,169
12th Oct 2026 (Mon) 1,400.00 1,406.00 1,396.00 1,406.00 36,780
9th Oct 2026 (Fri) 1,380.00 1,410.00 1,372.00 1,400.00 73,747
8th Oct 2026 (Thu) 1,420.00 1,420.00 1,348.00 1,364.00 113,932
7th Oct 2026 (Wed) 1,422.00 1,432.00 1,412.00 1,430.00 173,357
6th Oct 2026 (Tue) 1,456.00 1,466.00 1,420.00 1,448.00 50,320
5th Oct 2026 (Mon) 1,484.00 1,484.00 1,440.00 1,452.00 83,730
2nd Oct 2026 (Fri) 1,500.00 1,500.00 1,466.00 1,482.00 131,874
1st Oct 2026 (Thu) 1,526.00 1,532.00 1,500.00 1,500.00 32,795
30th Sep 2026 (Wed) 1,512.00 1,548.00 1,510.00 1,548.00 61,765
29th Sep 2026 (Tue) 1,534.00 1,556.00 1,510.00 1,510.00 53,608
28th Sep 2026 (Mon) 1,550.00 1,550.00 1,510.00 1,538.00 58,929
25th Sep 2026 (Fri) 1,560.00 1,568.00 1,538.00 1,548.00 47,924
24th Sep 2026 (Thu) 1,578.00 1,578.00 1,516.00 1,552.00 101,448
23rd Sep 2026 (Wed) 1,634.00 1,638.00 1,570.00 1,578.00 36,788
22nd Sep 2026 (Tue) 1,610.00 1,630.00 1,598.00 1,618.00 29,084
21st Sep 2026 (Mon) 1,602.00 1,620.00 1,600.00 1,608.00 70,406
18th Sep 2026 (Fri) 1,602.00 1,634.00 1,592.00 1,604.00 74,547
17th Sep 2026 (Thu) 1,600.00 1,642.00 1,600.00 1,634.00 17,088
See more Biotech Gwth price history

Biotech Gwth (BIOG) Regulatory News

Date Source Headline
16th Oct 2026 5:24 pm PRN Transaction in Own Shares
16th Oct 2026 2:41 pm PRN Net Asset Value(s)
15th Oct 2026 2:07 pm PRN Net Asset Value(s)
14th Oct 2026 3:11 pm PRN Monthly Fact Sheet as at 30 September 2026
14th Oct 2026 2:37 pm PRN Net Asset Value(s)
13th Oct 2026 2:00 pm PRN Net Asset Value(s)
12th Oct 2026 1:43 pm PRN Net Asset Value(s)
12th Oct 2026 7:00 am PRN Compliance with Market Abuse Regulation
9th Oct 2026 5:10 pm PRN Transaction in Own Shares
9th Oct 2026 2:09 pm PRN Net Asset Value(s)
See more Biotech Gwth regulatory news

Biotech Gwth (BIOG) Share News

EARNINGS AND TRADING: Allergy Therapeutics names next executive chair

28th Jul 2026 13:36

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

IN BRIEF: Biotech Growth says AtaiBeckley set for Eli Lilly takeover

17th Jul 2026 14:31

Biotech Growth Trust PLC - London-based investment trust - Eli Lilly & Co intends to acquire portfolio company AtaiBeckley Inc for approximately USD2.8 billion, or USD6.75 per share, in cash. This represents a 26% premium to AtaiBeckley's closing price on Wednesday. The offer also includes up to USD1 billion in contingent value rights linked to development and regulatory milestones, taking the potential value to USD3.8 billion, or USD9.25 per share, a 73% premium. AtaiBeckley is a clinical-stage biotechnology company focused on developing drugs to treat psychiatric disorders. BIOG says its AtaiBeckley holding accounted for 1.1% of its net asset value at the time of the announcement, and the transaction will be reflected in its Thursday NAV. Says this deal is the latest in a series of successful portfolio takeovers this year. Most recently, in May, French private equity firm ArchiMed SAS agreed to acquire investee Esperion Therapeutics. Read More

LONDON BRIEFING: Burberry US sales boost turnaround; Wise revenue up

17th Jul 2026 07:53

(Alliance News) - Burberry returns to first-quarter sales growth and raises its wholesale revenue guidance. Read More

EARNINGS AND TRADING: Vaultz Capital ousts CEO Benz, promotes Wood

3rd Jun 2026 19:08

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

Apellis investors respond to USD5.60 billion Biogen acquisition

1st Apr 2026 16:17

(Alliance News) - Biotech Growth Trust PLC, International Biotechnology Trust PLC, ad RTW Biotech Opportunities Ltd have all noted the agreement announced by Biogen Inc on Tuesday to acquire Apellis Pharmaceuticals, Inc. Read More

See more Biotech Gwth news
FTSE 100 Latest
Value10,881.90
Change41.55

Login to your account

Forgot Password?

Not Registered